WHO set to resume hydroxychloroquine trial in battle against COVID-19

Credit: Reuters- Published on June 3, 2020
The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
Advertisement

Video credit: HT Digital Content
Published on June 4, 2020 -  02:33
WHO set to resume hydroxychloroquine trial to battle covid-19
World Health Orgnanisation (WHO) said hydroxychloroquine (HCQ) will return to solidarity trial for potential treatment covid-19. The UN body had paused trials of the anti-malarial drug citing a Lancet study. The study had suggested the drug could cause more fatalities among Covid-19 patients. At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said, β€œThe Executive Group received this recommendation and endorsed continuation of all arms of the solidarity trial, including hydroxychloroquine.” Watch the video for more.

You are here

Related videos from verified sources

US Hospitals Cut Back On Use Of Hydroxychloroquine 00:32
Credit: Wochit Entertainment - Published on May 31, 2020 


WHO Puts The Brakes On Hydroxychloroquine Trials 00:35
Credit: Wochit Business - Published on May 26, 2020 


WHO Suspends Hydroxychloroquine Trial 00:49
Credit: Geo Beats - Published on May 25, 2020 


Related news from verified sources

The World Health Organization (WHO) is set to resume its trial of hydroxychloroquine for potential use against the new coronavirus, its head Tedros Adhanom...
on June 3, 2020 • Reuters

You might like